• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY Back to Search Results
Model Number 8888160341
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
The incident sample has been requested but to date has not been received for evaluation.If the sample is received, or if additional information pertinent to the incident is obtained a follow-up report will be submitted.
 
Event Description
The customer reported the umbilical artery catheter was placed by a nurse practitioner and a registered nurse (rn) connected fluids to the newly placed line.Shortly after initiating fluids, blood was noted to be backing up into the umbilical line.The rn noticed immediately and visualized a slow fluid leak from the umbilical catheter near the hub of the catheter.The line was clamped and the healthcare provider was notified.The line was removed and a new catheter was placed.
 
Manufacturer Narrative
A device history record review could not be performed because a lot number was not received with the complaint.As part of our manufacturing process, all device history records are reviewed and approved by quality, prior to release of product.One sample was returned to the plant for the investigation.The sample arrived in a generic plastic bag.The catheter showed signs of use (residues of blood).A visual inspection was performed and a leak below the strain relief was identified.The reported issue was confirmed.A definitive root cause could not be determined at this time.It must be noted that in-process controls (such as personnel training, incoming quality acceptance testing for raw material, 100% in process visual inspection and visual acceptance sampling) are in place to prevent nonconforming product from leaving the manufacturing operations.A corrective action is not applicable at this time.Functional testing and visual inspections are being performed according to our current quality standards and inspection procedures.This complaint will be used for qa tracking and trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
5.0FR URETHANE UMB CATH
Type of Device
CATHETER, UMBILICAL ARTERY
Manufacturer (Section D)
COVIDIEN
edificio b20 calle #2 zona fra
alajuela
CS 
MDR Report Key8493092
MDR Text Key141345135
Report Number3009211636-2019-00654
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 08/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number8888160341
Device Catalogue Number8888160341
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 04/03/2019
Initial Date FDA Received04/08/2019
Supplement Dates Manufacturer Received04/03/2019
Supplement Dates FDA Received08/05/2019
Patient Sequence Number1
-
-